CLYM
Climb Bio, Inc.
Company overview
- Market capitalization
- $674.30M
- Employees
- 28
- Latest publication
- 2026-09-29
About Climb Bio, Inc.
Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases. The company's lead product candidate is the budoprutug, an anti-CD19 monoclonal antibody for the treatment of B-cell mediated diseases. It is also developing budoprutug which is in phase 2 clinical trials for the treatment of primary membranous nephropathy and immune thrombocytopenia; and Phase 1b clinical trial indicated for the systemic lupus erythematosus. In addition, the company is developing CLYM116, a preclinical stage anti A Proliferation-inducing Ligand (APRIL) monoclonal antibody for the treatment of immunoglobin A nephropathy (IgAN) and other B-cell mediated diseases. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wellesley Hills, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 38,000USD | 30,000USD | 29,000USD | 38,000USD | — | — | — | — |
| Gross Profit | -38,000USD | -30,000USD | -29,000USD | -38,000USD | — | — | — | — |
| Research Development | 9,335,000USD | 13,738,000USD | 9,073,000USD | 6,575,000USD | 17,327,000USD | 5,959,000USD | 6,240,000USD | 52,705,000USD |
| Selling General Administrative | 5,838,000USD | 5,558,000USD | 5,819,000USD | 4,102,000USD | 5,691,000USD | 4,952,000USD | 5,492,000USD | 3,667,000USD |
| Total Operating Expenses | 15,173,000USD | 19,266,000USD | 14,892,000USD | 10,639,000USD | 23,018,000USD | 10,911,000USD | 11,732,000USD | 56,372,000USD |
| Operating Income | -15,211,000USD | -19,296,000USD | -14,892,000USD | -10,677,000USD | -23,018,000USD | -10,911,000USD | -11,732,000USD | -56,372,000USD |
| Interest Income | 1,514,000USD | — | — | 2,173,000USD | 2,287,000USD | — | — | 1,485,000USD |
| Net Interest Income | 1,514,000USD | — | — | 2,173,000USD | 2,287,000USD | — | — | 1,485,000USD |
| Income Before Tax | -13,722,000USD | -17,516,000USD | -12,888,000USD | -8,666,000USD | -20,781,000USD | -8,416,000USD | -8,895,000USD | -54,889,000USD |
| Net Income | -13,722,000USD | -17,516,000USD | -12,888,000USD | -8,666,000USD | -20,781,000USD | -8,416,000USD | -8,895,000USD | -54,889,000USD |
| Net Income From Continuing Ops | -13,722,000USD | -17,516,000USD | -12,888,000USD | -8,666,000USD | -20,781,000USD | -8,416,000USD | -8,895,000USD | -54,889,000USD |
| Ebit | -15,211,000USD | -19,296,000USD | -12,888,000USD | -8,666,000USD | -23,018,000USD | -10,911,000USD | -11,732,000USD | -56,372,000USD |
| Ebitda | -15,173,000USD | -19,266,000USD | -12,859,000USD | -8,628,000USD | -23,018,000USD | -10,911,000USD | -11,732,000USD | -56,372,000USD |
| Depreciation And Amortization | 38,000USD | 30,000USD | 29,000USD | 38,000USD | — | — | — | — |
| Reconciled Depreciation | 38,000USD | 30,000USD | 29,000USD | 38,000USD | 0USD | — | 0USD | — |
| Total Other Income Expense Net | 1,489,000USD | 1,780,000USD | 2,004,000USD | 2,011,000USD | 2,237,000USD | 2,495,000USD | 2,837,000USD | 1,483,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 97,000USD | — | — | — | — | — | — |
| Gross Profit | -97,000USD | — | — | — | — | — | — |
| Research Development | 46,616,000USD | 14,336,000USD | 15,411,000USD | 26,214,000USD | 23,322,000USD | 9,342,000USD | 4,019,000USD |
| Selling General Administrative | 21,170,000USD | 16,025,000USD | 24,864,000USD | 18,921,000USD | 12,350,000USD | 2,425,000USD | 677,000USD |
| Total Operating Expenses | 67,786,000USD | 82,020,000USD | 40,275,000USD | 45,135,000USD | 35,672,000USD | 20,925,000USD | 7,446,000USD |
| Operating Income | -67,883,000USD | -82,020,000USD | -40,275,000USD | -45,135,000USD | -35,672,000USD | -20,925,000USD | -7,446,000USD |
| Interest Income | 8,323,000USD | 8,132,000USD | 4,620,000USD | 1,375,000USD | — | — | — |
| Net Interest Income | 8,323,000USD | 8,132,000USD | 4,620,000USD | 1,375,000USD | — | — | — |
| Income Before Tax | -59,851,000USD | -73,897,000USD | -35,119,000USD | -45,244,000USD | -47,480,000USD | -20,668,000USD | -6,547,000USD |
| Net Income | -59,851,000USD | -73,897,000USD | -35,119,000USD | -45,244,000USD | -47,480,000USD | -20,668,000USD | -6,547,000USD |
| Net Income From Continuing Ops | -59,851,000USD | -73,897,000USD | -35,119,000USD | -45,244,000USD | -47,480,000USD | -20,668,000USD | — |
| Ebit | -67,883,000USD | -82,020,000USD | -40,275,000USD | -45,135,000USD | -35,672,000USD | -20,925,000USD | -7,446,000USD |
| Ebitda | -67,786,000USD | -30,361,000USD | -40,275,000USD | -45,135,000USD | -35,672,000USD | -11,767,000USD | -4,696,000USD |
| Depreciation And Amortization | 97,000USD | — | — | — | — | — | — |
| Reconciled Depreciation | 97,000USD | 0USD | — | — | — | — | — |
| Total Other Income Expense Net | 8,032,000USD | 8,123,000USD | 5,156,000USD | -109,000USD | -11,808,000USD | 257,000USD | 899,000USD |
| Unclassified Operating Expenses | — | 51,659,000USD | — | — | — | 9,158,000USD | 2,750,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 246,294,000USD | 152,372,000USD | 167,744,000USD | 182,304,000USD | 192,386,000USD | 200,740,000USD | 217,187,000USD | 222,199,000USD |
| Cash And Equivalents | 44,107,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 183,123,000USD | 109,564,000USD | 101,080,000USD | 86,901,000USD | 84,703,000USD | 98,062,000USD | 150,919,000USD | 193,351,000USD |
| Short Term Investments | 139,016,000USD | 101,208,000USD | 65,394,999USD | 61,098,000USD | 62,021,000USD | 69,042,000USD | 63,690,000USD | 47,176,000USD |
| Long Term Investments | 56,098,000USD | 36,741,000USD | 59,572,000USD | 88,930,000USD | 102,702,000USD | 99,783,000USD | 61,610,000USD | 24,576,000USD |
| Total Current Assets | 186,636,000USD | 113,404,000USD | 105,849,000USD | 90,964,000USD | 87,384,000USD | 100,280,000USD | 154,872,000USD | 197,611,000USD |
| Other Current Assets | 3,513,000USD | 3,840,000USD | 4,769,000USD | 4,063,000USD | 2,681,000USD | 852,000USD | 2,834,000USD | 3,270,000USD |
| Other Non Current Assets | 1,649,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 6,747,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 5,934,000USD | 4,070,999USD | 6,984,000USD | 4,949,000USD | 6,205,000USD | 7,036,000USD | 4,931,000USD | 3,423,000USD |
| Total Stockholder Equity | 239,547,000USD | 148,085,000USD | 160,475,000USD | 177,003,000USD | 185,764,000USD | 193,385,000USD | 211,881,000USD | 218,776,000USD |
| Total Equity Including Noncontrolling Interest | 239,547,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 1,911,000USD | 697,000USD | 793,000USD | 880,000USD | 932,000USD | 451,000USD | 490,000USD | 12,000USD |
| Accounts Payable | 1,133,000USD | 860,000USD | 2,269,000USD | 477,000USD | 946,000USD | 777,000USD | 705,000USD | 291,000USD |
| Short Term Debt | 501,000USD | 263,000USD | 256,000USD | 228,000USD | 222,000USD | 155,000USD | 157,000USD | 58,000USD |
| Common Stock | 6,000USD | 5,000USD | 5,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD |
| Retained Earnings | -316,947,000USD | -303,449,000USD | -289,727,000USD | -272,211,000USD | -259,323,000USD | -250,657,000USD | -229,876,000USD | -221,460,000USD |
| Accumulated Other Comprehensive Income | -67,000USD | 157,000USD | 435,000USD | 469,000USD | 318,000USD | 286,000USD | 23,000USD | 201,000USD |
| Total Liab | — | 4,287,000USD | 7,269,000USD | 5,301,000USD | 6,622,000USD | 7,355,000USD | 5,306,000USD | 3,423,000USD |
| Other Current Liab | — | 2,947,999USD | 4,459,000USD | 4,244,000USD | 5,037,000USD | 6,104,000USD | 4,069,000USD | 3,074,000USD |
| Capital Stock | — | 5,000USD | 5,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD |
| Cash | — | 8,356,000USD | 35,685,000USD | 25,803,000USD | 22,682,000USD | 29,020,000USD | 87,229,000USD | 146,175,000USD |
| Net Debt | — | -7,877,000USD | -35,144,000USD | -25,223,000USD | -22,043,000USD | -28,546,000USD | -86,697,000USD | -146,117,000USD |
| Short Long Term Debt Total | — | 479,000USD | 541,000USD | 580,000USD | 639,000USD | 474,000USD | 532,000USD | 58,000USD |
| Property Plant Equipment Gross | — | 697,000USD | 793,000USD | 880,000USD | 932,000USD | 451,000USD | 490,000USD | 12,000USD |
| Common Stock Shares Outstanding | — | 68,207,313shares | 67,369,230shares | 68,003,247shares | 67,585,121shares | 67,462,450shares | 64,738,462shares | 67,014,183shares |
| Non Current Assets Total | — | 38,968,000USD | 61,894,999USD | 91,340,000USD | 105,002,000USD | 100,460,000USD | 62,315,000USD | 24,588,000USD |
| Non Current Liabilities Total | — | 216,000USD | 285,000USD | 352,000USD | 417,000USD | 319,000USD | 375,000USD | 0USD |
| Non Currrent Assets Other | — | 1,530,000USD | 1,529,999USD | 1,530,000USD | 1,368,000USD | 226,000USD | 215,000USD | — |
| Net Working Capital | — | 109,333,000USD | 98,865,000USD | 86,015,000USD | 81,179,000USD | 93,244,000USD | 149,941,000USD | 194,188,000USD |
| Unclassified Equity | — | 451,367,000USD | 449,757,000USD | 448,731,000USD | 444,755,000USD | 443,742,000USD | 441,720,000USD | 440,021,000USD |
| Net Receivables | — | — | — | — | — | 1,366,000USD | 1,119,000USD | 990,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 167,744,000USD | 217,187,000USD | 110,469,000USD | 134,992,000USD | 173,241,000USD | 24,631,000USD | 21,395,000USD |
| Other Current Assets | 4,769,000USD | 2,834,000USD | 993,000USD | 4,335,000USD | 5,249,000USD | 1,511,000USD | 60,000USD |
| Total Liab | 7,269,000USD | 5,306,000USD | 2,870,000USD | 6,277,000USD | 6,038,000USD | 3,063,000USD | 783,000USD |
| Total Stockholder Equity | 160,475,000USD | 211,881,000USD | 107,599,000USD | 128,715,000USD | 167,203,000USD | 21,568,000USD | 20,612,000USD |
| Other Current Liab | 4,459,000USD | 4,069,000USD | 2,433,000USD | 5,047,000USD | 4,627,000USD | 1,977,000USD | 136,000USD |
| Common Stock | 5,000USD | 7,000USD | 3,000USD | 3,000USD | 3,000USD | 1,000USD | 1,000USD |
| Capital Stock | 5,000USD | 7,000USD | 3,000USD | 3,000USD | 3,000USD | 46,552,000USD | — |
| Retained Earnings | -289,727,000USD | -229,876,000USD | -155,979,000USD | -120,860,000USD | -75,616,000USD | -28,136,000USD | -7,468,000USD |
| Cash | 35,685,000USD | 87,229,000USD | 93,112,000USD | 43,585,000USD | 46,922,000USD | 20,487,000USD | 21,223,000USD |
| Cash And Short Term Investments | 101,080,000USD | 150,919,000USD | 106,798,000USD | 123,566,000USD | 136,480,000USD | 20,487,000USD | 21,223,000USD |
| Total Current Assets | 105,849,000USD | 154,872,000USD | 110,255,000USD | 134,393,000USD | 148,252,000USD | 21,998,000USD | 21,283,000USD |
| Total Current Liabilities | 6,984,000USD | 4,931,000USD | 2,833,000USD | 6,097,000USD | 6,031,000USD | 3,063,000USD | 783,000USD |
| Net Debt | -35,144,000USD | -86,697,000USD | -92,763,000USD | -43,105,000USD | -46,922,000USD | -20,487,000USD | -21,223,000USD |
| Short Term Debt | 256,000USD | 157,000USD | 334,000USD | 300,000USD | — | — | — |
| Short Long Term Debt Total | 541,000USD | 532,000USD | 349,000USD | 480,000USD | — | — | — |
| Long Term Investments | 59,572,000USD | 61,610,000USD | 0USD | 0USD | 24,919,000USD | 0USD | — |
| Short Term Investments | 65,394,999USD | 63,690,000USD | 13,686,000USD | 79,981,000USD | 89,558,000USD | 0USD | — |
| Accounts Payable | 2,269,000USD | 705,000USD | 66,000USD | 750,000USD | 1,404,000USD | 1,086,000USD | 647,000USD |
| Property Plant Equipment Net | 793,000USD | 490,000USD | 199,000USD | 471,000USD | 0USD | — | — |
| Property Plant Equipment Gross | 793,000USD | 490,000USD | 199,000USD | 471,000USD | 0USD | — | — |
| Accumulated Other Comprehensive Income | 435,000USD | 23,000USD | -2,000USD | -358,000USD | -123,000USD | — | — |
| Common Stock Shares Outstanding | 67,812,145shares | 48,163,301shares | 26,987,122shares | 26,311,554shares | 12,260,551shares | 11,661,662shares | 11,661,662shares |
| Non Current Assets Total | 61,894,999USD | 62,315,000USD | 214,000USD | 599,000USD | 24,989,000USD | 2,633,000USD | 112,000USD |
| Non Current Liabilities Total | 285,000USD | 375,000USD | 37,000USD | 180,000USD | 7,000USD | 0USD | — |
| Non Currrent Assets Other | 1,529,999USD | 215,000USD | 15,000USD | 128,000USD | 70,000USD | 2,633,000USD | 112,000USD |
| Net Working Capital | 98,865,000USD | 149,941,000USD | 107,422,000USD | 128,296,000USD | 142,221,000USD | 18,935,000USD | — |
| Unclassified Equity | 449,757,000USD | 441,720,000USD | 263,574,000USD | 249,927,000USD | 242,936,000USD | 3,151,000USD | 28,079,000USD |
| Net Receivables | — | 1,119,000USD | 2,464,000USD | 6,492,000USD | 6,523,000USD | — | — |
| Non Current Liabilities Other | — | — | 22,000USD | — | 7,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -13,722,000USD | -17,516,000USD | -12,888,000USD | -8,666,000USD | -20,781,000USD | -8,416,000USD | -8,895,000USD | -54,889,000USD |
| Depreciation | 38,000USD | 30,000USD | 29,000USD | 38,000USD | 0USD | — | 0USD | — |
| Stock Based Compensation | 1,605,000USD | 1,043,000USD | 3,976,000USD | 1,013,000USD | 2,022,000USD | 1,658,000USD | 2,922,000USD | 512,000USD |
| Other Non Cash Items | 1,378,999USD | 584,000USD | -468,000USD | -484,000USD | -606,000USD | -435,000USD | -268,000USD | 51,730,000USD |
| Change In Working Capital | -2,073,999USD | 1,267,000USD | -2,788,000USD | -3,011,000USD | 3,931,000USD | 1,672,000USD | -1,314,000USD | 1,980,000USD |
| Total Cash From Operating Activities | -14,379,000USD | -15,635,000USD | -12,139,000USD | -11,148,000USD | -15,434,000USD | -5,521,000USD | -7,555,000USD | -667,000USD |
| Capital Expenditures | 0USD | 0USD | -109,000USD | -77,000USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -14,379,000USD | -15,635,000USD | -12,248,000USD | -11,225,000USD | -15,434,000USD | -5,521,000USD | -7,555,000USD | -667,000USD |
| Investments | -12,955,000USD | 25,538,000USD | 15,260,000USD | 4,786,000USD | -42,751,000USD | -53,409,000USD | -71,789,000USD | -9,645,000USD |
| Total Cashflows From Investing Activities | -12,955,000USD | 25,538,000USD | 15,260,000USD | 4,786,000USD | -42,751,000USD | -53,409,000USD | -71,789,000USD | -9,645,000USD |
| Total Cash From Financing Activities | 5,000USD | -21,000USD | 0USD | 0USD | 0USD | 41,000USD | 2,271,000USD | 128,401,999USD |
| Change In Cash | -27,329,000USD | 9,882,000USD | 3,121,000USD | -6,338,000USD | -58,209,000USD | -58,946,000USD | -76,965,000USD | 118,109,000USD |
| Begin Period Cash Flow | 35,685,000USD | 25,803,000USD | 22,682,000USD | 29,020,000USD | 87,229,000USD | 146,175,000USD | 223,140,000USD | 105,031,000USD |
| End Period Cash Flow | 8,356,000USD | 35,685,000USD | 25,803,000USD | 22,682,000USD | 29,020,000USD | 87,229,000USD | 146,175,000USD | 223,140,000USD |
| Unclassified Operating Cash Flow | -1,605,000USD | -1,043,000USD | — | — | — | — | — | — |
| Issuance Of Capital Stock | — | 0USD | 0USD | — | — | 0USD | 0USD | — |
| Other Cashflows From Investing Activities | — | — | — | -77,000USD | — | — | — | -5,000,000USD |
| Other Cashflows From Financing Activities | — | — | — | — | — | 41,000USD | 2,271,000USD | 128,402,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | 5,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -59,851,000USD | -73,897,000USD | -35,119,000USD | -45,244,000USD | -47,480,000USD | -20,668,000USD | -6,547,000USD |
| Depreciation | 97,000USD | 0USD | — | — | — | — | — |
| Stock Based Compensation | 8,054,000USD | 5,557,000USD | 12,806,000USD | 6,991,000USD | 3,737,000USD | 707,000USD | — |
| Other Non Cash Items | 5,999,000USD | 51,080,000USD | -2,050,000USD | 674,000USD | 11,843,000USD | 8,799,000USD | 1,848,000USD |
| Change In Working Capital | -601,000USD | 1,698,000USD | 3,764,000USD | 210,000USD | -4,172,000USD | -2,936,000USD | -309,000USD |
| Total Cash From Operating Activities | -54,356,000USD | -15,562,000USD | -20,599,000USD | -37,369,000USD | -36,072,000USD | -14,098,000USD | -5,008,000USD |
| Capital Expenditures | -186,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -54,542,000USD | -15,562,000USD | -20,599,000USD | -37,369,000USD | -36,072,000USD | -14,098,000USD | -5,008,000USD |
| Investments | 3,019,000USD | -121,092,000USD | 68,981,000USD | 34,440,000USD | -114,970,000USD | 8,078,000USD | — |
| Total Cashflows From Investing Activities | 2,833,000USD | -121,092,000USD | 68,981,000USD | 34,440,000USD | -114,970,000USD | 8,078,000USD | — |
| Total Cash From Financing Activities | -21,000USD | 130,729,000USD | 841,000USD | 0USD | 177,232,000USD | 4,925,000USD | 26,243,000USD |
| Issuance Of Capital Stock | 0USD | 119,750,000USD | 0USD | 0USD | 177,083,000USD | 4,925,000USD | — |
| Change In Cash | -51,544,000USD | -5,883,000USD | 49,527,000USD | -3,337,000USD | 26,435,000USD | -736,000USD | 21,223,000USD |
| Begin Period Cash Flow | 87,229,000USD | 93,112,000USD | 43,585,000USD | 46,922,000USD | 20,487,000USD | 21,223,000USD | — |
| End Period Cash Flow | 35,685,000USD | 87,229,000USD | 93,112,000USD | 43,585,000USD | 46,922,000USD | 20,487,000USD | 21,223,000USD |
| Unclassified Operating Cash Flow | -8,054,000USD | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | -9,645,000USD | — | — | — | 8,078,000USD | — |
| Other Cashflows From Financing Activities | — | 10,979,000USD | 841,000USD | — | 94,088,000USD | 4,925,000USD | 26,243,000USD |
| Unclassified Investing Cash Flow | — | 9,645,000USD | — | — | — | -8,078,000USD | — |
| Unclassified Financing Cash Flow | — | — | — | — | -93,939,000USD | -4,925,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.